NIKOLA CORP (NKLA)
US6541103031 - Common Stock
We assign a fundamental rating of 2 out of 10 to NKLA. NKLA was compared to 132 industry peers in the Machinery industry. NKLA has a bad profitability rating. Also its financial health evaluation is rather negative. NKLA shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year NKLA has reported negative net income.
NKLA had a negative operating cash flow in the past year.
NKLA had negative earnings in 4 of the past 5 years.
In the past 5 years NKLA always reported negative operating cash flow.
1.2 Ratios
NKLA has a Return On Assets of -61.27%. This is amonst the worse of the industry: NKLA underperforms 91.54% of its industry peers.
The Return On Equity of NKLA (-167.38%) is worse than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -61.27% | ||
| ROE | -167.38% | ||
| ROIC | N/A |
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for NKLA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NKLA has been reduced compared to 1 year ago.
NKLA has more shares outstanding than it did 5 years ago.
NKLA has a better debt/assets ratio than last year.
2.2 Solvency
NKLA has an Altman-Z score of -6.32. This is a bad value and indicates that NKLA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NKLA (-6.32) is worse than 89.23% of its industry peers.
NKLA has a Debt/Equity ratio of 0.72. This is a neutral value indicating NKLA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.72, NKLA is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.32 |
ROIC/WACCN/A
WACC4.68%
2.3 Liquidity
NKLA has a Current Ratio of 1.17. This is a normal value and indicates that NKLA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.17, NKLA is doing worse than 89.23% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that NKLA may have some problems paying its short term obligations.
NKLA has a worse Quick ratio (0.94) than 70.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 66.31% over the past year.
Looking at the last year, NKLA shows a very strong growth in Revenue. The Revenue has grown by 141.23%.
NKLA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 610.32% yearly.
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
Revenue 1Y (TTM)141.23%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Sales Q2Q%1553.87%
3.2 Future
Based on estimates for the next years, NKLA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.89% on average per year.
The Revenue is expected to grow by 129.36% on average over the next years. This is a very strong growth
EPS Next Y55.72%
EPS Next 2Y29.38%
EPS Next 3Y20.99%
EPS Next 5Y14.89%
Revenue Next Year188.24%
Revenue Next 2Y194.08%
Revenue Next 3Y167.85%
Revenue Next 5Y129.36%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
NKLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NKLA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
NKLA's earnings are expected to grow with 20.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.38%
EPS Next 3Y20.99%
5. Dividend
5.1 Amount
NKLA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NIKOLA CORP
NASDAQ:NKLA (12/20/2024, 8:00:01 PM)
After market: 1.18 0 (0%)1.18
+0.01 (+0.85%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners132.99%
Inst Owner Change377.07%
Ins Owners23.1%
Ins Owner Change0.22%
Market Cap71.83M
Analysts75
Price Target5.61 (375.42%)
Short Float %23.14%
Short Ratio1.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.31%
Min EPS beat(2)-14.66%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)4.83%
Min EPS beat(4)-14.66%
Max EPS beat(4)17.04%
EPS beat(8)6
Avg EPS beat(8)-7.88%
EPS beat(12)10
Avg EPS beat(12)2.84%
EPS beat(16)14
Avg EPS beat(16)10.41%
Revenue beat(2)1
Avg Revenue beat(2)-10.23%
Min Revenue beat(2)-33.69%
Max Revenue beat(2)13.22%
Revenue beat(4)1
Avg Revenue beat(4)-21.12%
Min Revenue beat(4)-53.46%
Max Revenue beat(4)13.22%
Revenue beat(8)1
Avg Revenue beat(8)-37.14%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-66.67%
PT rev (3m)-68.02%
EPS NQ rev (1m)-1.62%
EPS NQ rev (3m)-2292.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)1.96%
Revenue NQ rev (3m)-24.18%
Revenue NY rev (1m)-0.76%
Revenue NY rev (3m)-16.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.95 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.19 | ||
| P/tB | 0.22 | ||
| EV/EBITDA | N/A |
EPS(TTM)-11.42
EYN/A
EPS(NY)-8.51
Fwd EYN/A
FCF(TTM)-9.42
FCFYN/A
OCF(TTM)-8.5
OCFYN/A
SpS1.24
BVpS6.23
TBVpS5.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -61.27% | ||
| ROE | -167.38% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 137.76% | ||
| Cap/Sales | 73.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | -6.32 |
F-Score4
WACC4.68%
ROIC/WACCN/A
Cap/Depr(3y)1082.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
EPS Next Y55.72%
EPS Next 2Y29.38%
EPS Next 3Y20.99%
EPS Next 5Y14.89%
Revenue 1Y (TTM)141.23%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Sales Q2Q%1553.87%
Revenue Next Year188.24%
Revenue Next 2Y194.08%
Revenue Next 3Y167.85%
Revenue Next 5Y129.36%
EBIT growth 1Y25.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.03%
EBIT Next 3Y20.23%
EBIT Next 5Y25.05%
FCF growth 1Y21.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.78%
OCF growth 3YN/A
OCF growth 5YN/A